Catalyst Wire Dossier Catalyst Wire Dossier

Pegylated interleukin-2

polyethylene glycol-conjugated interleukin-2
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegylated interleukin-2, covering 2008-08-04 to 2008-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals [Phase 1]

See pricing